Prescription rate of erythropoietin-stimulating agents is low for patients with renal impairment under non-nephrology care in a tertiary-level academic medical center in Japan
- Naoki Okamoto
- Daijo Inaguma
- et al.
- 2022
- Clinical and Experimental Nephrology